BE748897A - Procede pour la realisation de formes pharmaceutiques deshydratees ou desolvatees par lyophilisation et formes pharmaceutiques ainsi obtenus - Google Patents

Procede pour la realisation de formes pharmaceutiques deshydratees ou desolvatees par lyophilisation et formes pharmaceutiques ainsi obtenus

Info

Publication number: BE748897A
Authority: BE; Belgium
Prior art keywords: pharmaceutical forms; desolvated; lyophilization; realization; dehydrated
Prior art date: 1969-04-15

Application number

Other languages

English (en)

Inventor

P Blonde Le

Original Assignee

Orsymonde

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1969-04-15

Filing date

1970-04-14

Publication date

1970-09-16

1969-04-15 Priority claimed from FR696911589A external-priority patent/FR2036890B1/fr

1970-01-24 Priority claimed from FR7010548A external-priority patent/FR2081586A2/fr

1970-04-14 Application filed by Orsymonde filed Critical Orsymonde

1970-09-16 Publication of BE748897A publication Critical patent/BE748897A/fr

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicinal Preparation (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)

BE748897D 1969-04-15 1970-04-14 Procede pour la realisation de formes pharmaceutiques deshydratees ou desolvatees par lyophilisation et formes pharmaceutiques ainsi obtenus BE748897A (fr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR696911589A FR2036890B1 (fr)	1969-04-15	1969-04-15
FR7010548A FR2081586A2 (en)	1970-01-24	1970-01-24	Dehydrated pharmaceutical comps by - lyophilisation

Publications (1)

Publication Number	Publication Date
BE748897A true BE748897A (fr)	1970-09-16

Family

ID=26214959

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BE748897D BE748897A (fr)	1969-04-15	1970-04-14	Procede pour la realisation de formes pharmaceutiques deshydratees ou desolvatees par lyophilisation et formes pharmaceutiques ainsi obtenus

Country Status (4)

Country	Link
US (1)	US3778510A (fr)
BE (1)	BE748897A (fr)
DE (1)	DE2017373A1 (fr)
GB (1)	GB1310824A (fr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3928566A (en) *	1970-08-14	1975-12-23	Du Pont	Lyophilized biological products
GB1548022A (en) *	1976-10-06	1979-07-04	Wyeth John & Brother Ltd	Pharmaceutial dosage forms
IE45770B1 (en) *	1976-10-06	1982-11-17	Wyeth John & Brother Ltd	Pharmaceutical dosage forms
CA1097233A (fr)	1977-07-20	1981-03-10	George K. E. Gregory	Emballages
FR2539626B2 (fr) *	1983-01-25	1985-06-21	Lafon Labor	Nouveau procede de preparation de formes galeniques utiles notamment en therapeutique, dietetique, cosmetique et diagnostic, et formes obtenues selon ce procede
FR2561916B1 (fr) *	1984-03-30	1987-12-11	Lafon Labor	Forme galenique pour administration orale et son procede de preparation par lyophilisation d'une emission huile dans eau
DE3628468A1 (de) *	1986-08-21	1988-03-03	Thomae Gmbh Dr K	Neue applikationsformen fuer (alpha)-interferone
DE3801179A1 (de) *	1988-01-18	1989-07-27	Hoechst Ag	Stabilisierung von cephalosporinderivaten durch trocknung mit einem stabilisator sowie stabile zubereitungsformen mit cephalosporinderivaten
DE3801178A1 (de) *	1988-01-18	1989-07-27	Hoechst Ag	Stabilisierte trockenzubereitung zytostatisch wirksamer anthracyclin-antibiotika und verfahren zu ihrer herstellung
FR2634376B1 (fr) *	1988-07-21	1992-04-17	Farmalyoc	Nouvelle forme unitaire, solide et poreuse comprenant des microparticules et/ou des nanoparticules, ainsi que sa preparation
US5334395A (en) *	1988-08-04	1994-08-02	Kremers-Urban Company	Method of treating an epstein-barr viral infection
US5055296A (en) *	1988-08-04	1991-10-08	Wagle Sudhakar S	Method of treating chronic fatigue syndrome
US5316775A (en) *	1988-08-04	1994-05-31	Kremers-Urban Company	Method of treating hepatitis B infection
US5284664A (en) *	1988-08-04	1994-02-08	Kremers-Urban Company	Method of treating the symptoms of Alzheimer's disease
US5206025A (en) *	1989-05-24	1993-04-27	Rhone-Poulenc Sante	Porous pharmaceutical form and its preparation
US5215756A (en) *	1989-12-22	1993-06-01	Gole Dilip J	Preparation of pharmaceutical and other matrix systems by solid-state dissolution
GR910100193A (el) *	1991-05-03	1993-03-31	Mediventures Inc	Παρασκευη φαρμακευτικων και αλλων περιβληματων με διαλυση σε στερεα κατασταση.
IL101007A (en) *	1992-02-18	1997-08-14	Pharmos Ltd	Dry stable compositions prepared by lyophilization
IL105553A (en)	1992-05-06	1998-01-04	Janssen Pharmaceutica Inc	Solid dosage forms consisting of a porous network of matrix that releases a substance that dissipates rapidly in water
ES2206129T5 (es) *	1999-12-22	2007-11-01	Dsm Ip Assets B.V.	Composicion que comprende acido ascorbico como componente principal y pectina.
ES2250711T3 (es) *	2001-09-03	2006-04-16	Dsm Ip Assets B.V.	Composiciones que comprenden pectina y acido ascorbico.
DE10254334A1 (de) *	2002-11-21	2004-06-03	Beiersdorf Ag	Kosmetikkonzentrat
ES2811307T3 (es)	2009-04-22	2021-03-11	Medskin Solutions Dr Suwelack Ag	Composición de principios activos liofilizada

1970
- 1970-04-11 DE DE19702017373 patent/DE2017373A1/de not_active Withdrawn
- 1970-04-14 BE BE748897D patent/BE748897A/fr not_active IP Right Cessation
- 1970-04-15 GB GB1799570A patent/GB1310824A/en not_active Expired
1972
- 1972-08-22 US US00282832A patent/US3778510A/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
US3778510A (en)	1973-12-11
DE2017373A1 (de)	1971-04-22
GB1310824A (en)	1973-03-21

Similar Documents

Publication	Publication Date	Title
BE748897A (fr)	1970-09-16	Procede pour la realisation de formes pharmaceutiques deshydratees ou desolvatees par lyophilisation et formes pharmaceutiques ainsi obtenus
FR2286511A2 (fr)	1976-04-23	Joint pour connexion et son procede de realisation
BE776357A (fr)	1972-04-04	Compositions pharmaceutiques et procede pour les
BE807706A (fr)	1974-05-24	Procede pour la preparation de cycloalcanones et/ou cycloalcanols
BE776518A (fr)	1972-06-12	Procede pour la preparation de polylactones
BE776784A (fr)	1972-06-16	Procede pour la preparation de derives hydroperoxydes de polymeres
BE744478A (fr)	1970-06-15	Procede de preparation de produits conjugues bacteriophage - proteine et nouveaux produits ainsi obtenus
BE744641A (fr)	1970-07-01	Procede pour la preparation de 2-mercapto-benzthiazol
BE812811A (fr)	1974-07-15	Nouveau procede de preparation des formes pharmaceutiques deshydratees ou desolvatees par lyophilisation
BE777265A (fr)	1972-04-17	Procede de preparation de 1,5-dimethyl-naphtalene et/ou de 1-6-dimethyl-naphtalene et composition catalytique utilisee pour ledit procede
BE776530A (fr)	1972-06-12	Procede pour la preparation de 5-vinylnorbornene-2
BE773013A (fr)	1972-03-24	Procede pour la preparation de peptides
BE756350A (fr)	1971-03-18	Procede pour la preparation de 5-methylene-2, 4-oxazolidine-diones et composes ainsi obtenus
BE806277A (fr)	1974-04-19	Procede pour la preparation de cycloalcanones et de cycloalcanols
BE745938A (fr)	1970-08-13	Procede pour la preparation de cycloalcenones
BE754420A (fr)	1971-01-18	Procede pour la preparation de 4-ureidohexahydropyrimidinone -(2)
BE762598A (fr)	1971-08-05	Procede pour la preparation de 2-ethylhexanal-(1)
BE764203A (fr)	1971-09-13	Procede pour la preparation d'indenophtalazines
BE772818A (fr)	1972-03-20	Procede pour la preparation de derives de
BE745469A (fr)	1970-08-04	Procede pour la preparation de gamma-cyanobutyraldimines
BE763637A (fr)	1971-08-02	Procede pour la preparation de thiourees symetriques 1,3- disubstitueesaliphatiques et cycloaliphatiques
BE766147A (fr)	1971-10-22	Procede pour la preparation de steroides
BE773173A (fr)	1972-03-28	Procede pour la preparation de beta-lactames n-substituees 3,3-disubstituees
BE744915A (fr)	1970-07-01	Procede pour la preparation de 4-carboxy-2-piperidone et de sesesters
BE761685A (fr)	1971-07-19	Procede pour la preparation d'isoxazolylethyl-tetrahydropyranols

Legal Events

Date	Code	Title	Description
1990-01-01	RE20	Patent expired	Owner name: ORSYMONDE Effective date: 19900414

Date

Code

Title

Description

1990-01-01

RE20

Patent expired

Owner name: ORSYMONDE

Effective date: 19900414